MK-0249 is a potent histamine H3 receptor antagonist, with Ki of 1.7 nM for human H3.
[1]. Brioni JD, et al. Discovery of histamine H3 antagonists for the treatment of cognitive disorders and Alzheimer's disease. J Pharmacol Exp Ther. 2011 Jan;336(1):38-46.
















